Drug Database
TR

trivalent rotavirus gene reassortment oral vaccine

✓ Approved

Lanzhou Institute · 疫苗 · 疫苗

什么是 trivalent rotavirus gene reassortment oral vaccine?

trivalent rotavirus gene reassortment oral vaccine 是一种疫苗,由Lanzhou Institute研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

公司Lanzhou Institute
药物类别疫苗
给药途径Oral (PO)
状态Approved

治疗适应症

trivalent rotavirus gene reassortment oral vaccine 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsGastroenteritis✓ Approved
Infections and infestationsRotavirus infection✓ Approved

相关研究文献

PubMedMicrobial cell factories2026-11-17

Construction and immunogenicity evaluation of recombinant Bacillus subtilis expressing VP8 protein of porcine rotavirus.

Wang Zhikui Z, Yan Xinping X, Wang Xu X, Yue Xiaoxue X et al.

Porcine rotavirus (PoRV), an enteric infectious virus, is a major cause of neonatal diarrhea in piglets, resulting in significant economic losses to the global swine industry. In this study, the cholera toxin B subunit (CTB) was utilized as a molecular adjuvant to construct recombinant Bacillus subtilis (B. subtilis) strains expressing VP8 proteins and CTB-VP8 fusion proteins derived from the PoRV genotypes P[7], P[13], and P[23]. The recombinant strains expressing PoRV proteins from different genotypes were combined and orally administered to mice, and their immunogenicity and probiotic functions were evaluated. The results demonstrated that the recombinant B. subtilis significantly increased serum-specific IgG and fecal-specific sIgA antibodies levels (P < 0.001), indicating that the recombinant strains induced both humoral and mucosal antibody responses in mice. Notably, the CTB-fused strains elicited higher titers of IgG and sIgA. Furthermore, the recombinant strains significantly elevated the expression levels of cytokines, including IFN-γ, IL-2, and IL-4, in both serum and intestinal mucosa (P < 0.01), suggesting a Th1/Th2-biased immune response at the cytokine level. In addition, administration of recombinant B. subtilis increased villus height and the villus height-to-crypt depth ratio while reducing crypt depth, showing a tendency to improve intestinal morphology. This study addresses the limitations associated with insufficient mucosal immune activation by conventional injectable approaches and the absence of cross-protection among different genotypes of PoRV, thereby providing a theoretical foundation for the development of an oral trivalent live-vector vaccine.

PMID 43040377
阅读全文 →
PubMedVeterinary research communications2026-11-17

Construction and preliminary safety evaluation of an ATCC 14​028-derived ΔcrpΔcyaΔasd(pYA3493) balanced-lethal Salmonella Typhimurium candidate vaccine vector in Wenchang chicks.

Wang Han H, Ran Xuhua X, Wen Xiaobo X

Attenuated Salmonella enterica serovar Typhimurium strains are widely used as live bacterial vectors for heterologous antigen delivery. However, the biological performance of attenuated Salmonella vectors can vary depending on the parental genetic background. Therefore, strain-specific characterization is important for the development of suitable poultry vaccine platforms. In this study, comparative genomic analysis was first performed to characterize the genetic background of S. Typhimurium ATCC 14​028 in comparison with LT2, SL1344, and UK-1. Major virulence-associated systems were conserved among the four strains; however, ATCC 14​028 contained distinct accessory genomic regions, including a prophage-associated region, indicating strain-specific genomic variation. Based on this genetic characterization, an ATCC 14​028-derived ΔcrpΔcyaΔasd strain carrying the Asd-based balanced-lethal plasmid pYA3493 was constructed and evaluated. The ΔcrpΔcyaΔasd strain exhibited DAP-dependence, whereas the pYA3493-complemented strain grew in the absence of DAP. pYA3493-associated sequences remained detectable during serial passage, and EGFP expression confirmed its heterologous protein-expression capacity. In young chicks, oral administration of the attenuated strain resulted in lower mortality, reduced tissue bacterial burdens, and milder pathological changes compared with wild-type ATCC 14​028. The attenuated strain was recovered from intestinal and systemic tissues during the early post-inoculation period, but bacterial recovery decreased over time and was below the culture detection limits by 14 dpi. These findings provide preliminary safety data for this candidate vector in Wenchang chicks under the conditions examined and support its further evaluation for poultry vaccine applications.

PMID 43040178
阅读全文 →
PubMedFrontiers in veterinary science2026-11-17

Integrated HPAIV surveillance at a crane wintering site in the Izumi Plain.

Esaki Mana M, Okuya Kosuke K, Ozawa Makoto M

The Izumi Plain, Japan, is a major wintering site for endangered cranes adjacent to intensive poultry production, creating an important interface for avian influenza virus (AIV) surveillance. This Review synthesizes more than a decade of environmental and wild-bird surveillance, focusing on water collected from artificial crane roosts. Initially, virus isolation from roost water was inefficient, yielding few isolates. A modified procedure introduced in the 2018/19 season markedly improved isolation efficiency, yielding 44 low pathogenicity avian influenza viruses (LPAIVs) that season. The increased availability of infectious isolates enabled whole-genome analyses that revealed subtype diversity, reassortment, and genotype turnover, transforming roost-water surveillance from sporadic detection into a tool for characterizing AIV circulation. During the 2022/23 high pathogenicity avian influenza (HPAI) outbreak, extensive crane mortality contrasted with limited HPAIV isolation from roost water, highlighting the limitations of environmental surveillance alone. Integrating environmental, host-based, serological, and genomic data provides a more comprehensive understanding of HPAIV dynamics and strengthens surveillance at high-density wild-bird aggregation sites.

PMID 43041552
阅读全文 →
PubMedBMC public health2026-11-17

Post-introduction evaluation of COVID-19 vaccine deployment in Ghana: lessons learnt to inform future new vaccine introductions and strengthen public health readiness, 2023.

Amponsa-Achiano Kwame K, Shen Angela K AK, Baiden Laryea Eunice E, Carlton Julie Garon JG et al.

On March 2nd, 2021, Ghana, the first country to receive vaccines from the COVAX facility, began its COVID-19 vaccination using a complex multi-phased approach, to reach target populations. We evaluated the vaccine deployment to document best practices challenges and lessons for future new vaccine introductions and public health emergency readiness. We conducted a mixed methods post-introduction evaluation, purposively sampling 36 facilities from 12 districts in six regions. Adapting the World Health Organization's COVID-19 Post-Introduction Evaluation tool, we conducted a cross-sectional survey using a structured questionnaire, reviewed programme records, observed practices, and interviewed purposively selected health workers, immunization managers and partners who supported vaccine deployment. We performed summary descriptive statistics on quantitative data, thematic analysis on qualitative data, and triangulated the results. As of March 2023, more than 70% of the target population (15 years and older) had received at least one dose, while more than 50% had completed the primary series. Vaccine deployment was built on the existing immunisation programme and functional coordinating bodies. Cold chain capacity was revamped with ultra-low-temperature freezers, while 33.3% of surveyed districts adjusted waste disposal systems to accommodate COVID-19 vaccine introduction. Door-to-door delivery and demand generation through varied risk communication and community engagement strategies improved vaccine access. Electronic data platforms were established, surge capacity improved, and healthcare and community workers were trained. Initial unpredictable vaccine supplies limited vaccination efforts. Changing vaccine information affected health workers' ability to engage communities with up-to-date guidance. While vaccine safety monitoring systems were in place, reporting knowledge varied among health workers, and 36% of surveyed facilities had ever documented and reported COVID-19 vaccine-related adverse events following immunisation. Challenges with electronic data systems limited timely access to and use of granular service-delivery data for decision-making. Ghana leveraged existing immunisation and emergency-response systems to make substantial progress in COVID-19 vaccine deployment. Coordination, cold chain expansion, flexible service delivery, demand generation and workforce mobilisation supported implementation. Irregular vaccine supply, data system challenges, variable adverse event reporting, waste management pressure and misinformation challenged deployment. These findings provide lessons for adult immunisation, life-course vaccination and future public health emergency readiness.

PMID 43040294
阅读全文 →
PubMedACI open2026-11-17

Enhancing Human Papillomavirus Vaccine Communication with Mobile Health: Usability Insights from Caregivers and Health Care Providers.

Reisher Elizabeth E, Anyanwu Evangel E, Figliomeni Jonathan J, Honcoop Adrien A et al.

Despite the effectiveness of the human papillomavirus (HPV) vaccine in preventing cancer, uptake remains suboptimal, especially among rural and underserved populations. Digital communication tools such as mobile health (mHealth) applications have the potential to improve access to accurate vaccine information and support shared decision-making. This study aimed to assess the usability, acceptability, and perceived usefulness of a newly developed mHealth app for HPV vaccine communication in comparison to the Centers for Disease Control and Prevention's (CDC) HPV vaccine Web site. Using a mixed-methods design and guided by the Health Belief Model and the mHealth Agile Development and Evaluation Lifecycle, caregivers, and health care providers were randomized to explore both the CDC Web site and the mHealth app in alternating order. Participants were asked to complete a session answering HPV vaccine questions with each tool and completed the mHealth App Usability Questionnaire, Propensity to Trust, and NASA Task Load Index (NASA-TLX) after each session. Qualitative questions were asked after each session to capture additional feedback on items such as navigation and readability. Transcripts were analyzed using inductive thematic analysis. Quantitative results showed no difference between the tools in terms of being easy to use, requiring similar amounts of effort, and trust in the tool. Qualitative themes revealed that participants appreciated the app's streamlined navigation, tailored content, and readability. In contrast, the CDC Web site was seen as credible but often difficult to navigate, especially when searching for nuanced or specific vaccine information. Tailored mHealth tools developed with user-centered design principles may better meet the informational and usability needs of caregivers and health care providers compared with existing web-based resources. These findings support further development and integration of mHealth tools into vaccine communication strategies to enhance HPV vaccine communication.

PMID 43042227
阅读全文 →
PubMedInfection and immunity2026-11-17

Co-administration of DTaP with COVID-19 mRNA vaccine in mice alters immune responses and induces increased protection from Bordetella pertussis challenge.

Rader Nathaniel N, Boehm Dylan T DT, Bitzer Graham J GJ, Chapman Joshua J et al.

During the COVID-19 pandemic, children received COVID-19 mRNA vaccines alongside other regularly scheduled immunizations, such as the acellular Bordetella pertussis vaccine DTaP. It is known that mRNA vaccines are pro-inflammatory in nature, leading to protective immunity against SARS-CoV-2 infection. The goal of this study was to investigate the potential adjuvanticity of co-administration of a COVID-19 mRNA vaccine alongside DTaP. Mice were immunized with DTaP alone or with a co-administration of DTaP plus COVID-19 mRNA vaccine. To understand the impact of co-administration, we evaluated protection against B. pertussis aerosol challenge in mice and potential correlates of protection, including cytokine responses to vaccination, antibody responses, and single-cell transcriptomic analysis of the draining lymph node. Three decreasing doses of each vaccine were used to simulate waning immunity. Overall, compared to mice immunized with DTaP, co-administration of DTaP + COVID-19 mRNA vaccines elicited higher pro-inflammatory cytokine responses, higher IgG2b antibody responses, and mice were afforded increased protection against aerosol challenge of B. pertussis. Single-cell transcriptomics studies on the lymph node of vaccinated mice at 1 day post-boost further characterized how co-administration of COVID-19 mRNA vaccine alongside DTaP vaccine shapes immunity. Single-cell transcriptomics revealed that co-administration of DTaP and COVID-19 mRNA vaccine generated populations of B and T cells with upregulated expression of interferon-stimulated genes, which were absent when vaccinating with DTaP alone. Altogether, these data suggest that administering DTaP alongside COVID-19 mRNA vaccine alters immune responses and provides increased protection from an aerosol challenge of B. pertussis compared to DTaP alone in mice.

PMID 43043313
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多trivalent rotavirus gene reassortment oral vaccine